Brief: Nxera Announces Successful Resolution Of Minig Patent Infringement Action
01/10/2026 11:29
BRIEF-Nxera Announces Successful Resolution Of Minig Patent Infringement Action Oct 1 (Reuters) - Nxera Pharma Co., Ltd. 4565.T:
NXERA ANNOUNCES SUCCESSFUL RESOLUTION OF MINIG PATENT INFRINGEMENT ACTION
NXERA PHARMA CO., - SETTLEMENT RESOLVES PATENT INFRINGEMENT PROCEEDINGS IN ENGLAND AND WALES; TERMS CONFIDENTIAL
NXERA PHARMA CO., - TO CONTINUE ENFORCEMENT OF INTELLECTUAL PROPERTY FOR NXWAVE PLATFORM
Source text: ID:nGNX5c0zR7
Further company coverage: 4565.T
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Nxera Pharma
See all newsNxera Pharma Submits Marketing Authorization Application For Vamorolone In South Korea For Treatment Of Duchenne Muscular Dystrophy
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Brief: Nxera Pharma - Entered Into Exclusive License, Supply And Commercialization Agreement With Synmosa For Quviviq Across Eight Asia-Pacific Markets
Brief: Nxera Announces Successful Resolution Of Minig Patent Infringement Action
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up